News Quantified

ITRM – iterum therapeutics plc - ordinary share (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 [Yahoo! Finance]

Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024

Iterum Therapeutics plc (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem [Yahoo! Finance]

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

-3.8%

BEAT

-3.8%

BEAT

Form 8-K Iterum Therapeutics plc For: Apr 29

Form ARS Iterum Therapeutics plc For: Dec 31

Form DEFA14A Iterum Therapeutics plc

Form DEF 14A Iterum Therapeutics plc For: Jun 19

Form 8-K Iterum Therapeutics plc For: Apr 03

Top News Gainers

12/26 Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infection 95.5%

12/11 Iterum Therapeutics PLC (NASDAQ: ITRM) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "market perform" rating. 20.0%

4/27 Form PRE 14A Iterum Therapeutics plc For: Jun 10 15.4%

2/19 Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference 11.0%

12/1 Is Iterum Therapeutics plc (ITRM) Going To Burn These Hedge Funds ? [Yahoo! Finance News] 9.7%

3/16 Form S-8 Iterum Therapeutics plc 7.8%

11/18 Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection 6.0%

11/15 Iterum Therapeutics PLC (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at G.Research, Llc. 4.7%

1/23 Form 4 Iterum Therapeutics plc For: Jan 21 Filed by: CANAAN X L.P. 3.8%

4/9 Iterum Therapeutics PLC (NASDAQ: ITRM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock. 3.6%

Top News Decliners

12/10 Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections -37.0%

1/17 Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors -26.0%

3/13 Iterum Therapeutics PLC (NASDAQ: ITRM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. -19.3%

1/21 Iterum Therapeutics PLC (NASDAQ: ITRM) was downgraded by analysts at Gabelli from a "buy" rating to a "sell" rating. -13.5%

8/14 Form 8-K Iterum Therapeutics plc For: Aug 14 -11.0%

10/4 Iterum Therapeutics PLC (NASDAQ: ITRM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -10.9%

3/12 Q4/2019 12/31/2019 EPS -1.590 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%

11/19 Iterum Therapeutics PLC (NASDAQ: ITRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -9.0%

1/22 Iterum Therapeutics PLC (NASDAQ: ITRM) was downgraded by analysts at G.Research, Llc from a "buy" rating to a "sell" rating. -8.3%

1/27 Form SC 13D/A Iterum Therapeutics plc Filed by: New Leaf Venture Management III, L.L.C. -7.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day